Very pleased with the content of the CEMI.ob announcement. Test results look spectacular. This is the first major approval for Chembio's DPP tests. Bodes well for upcoming approvals in Brazil, Europe and the US over the next couple of years.
Imagine being able to discuss your tests immediately with your doctor instead of scheduling a followup visit because you have to wait for lab results. Especially important in third world countries where doctors and treatment are not always available.
Their DPP product could be a company maker for Chembio. It's going to take awhile to show up in the P&L but I think this is a long term winner.
News 
Market Data 
Discover 
